Fasciolosis, due to Fasciola hepatica and Fasciola gigantica, is a re-emerging zoonotic parasitic disease of worldwide importance. Human and animal infections are commonly diagnosed by the traditional sedimentation and faecal egg-counting technique. However, this technique is time-consuming and prone to sensitivity errors when a large number of samples must be processed or if the operator lacks sufficient experience. Additionally, diagnosis can only be made once the 12-week pre-patent period has passed. Recently, a commercially available coprological antigen ELISA has enabled detection of F. hepatica prior to the completion of the pre-patent period, providing earlier diagnosis and increased throughput, although species differentiation is not possible in areas of parasite sympatry. Real-time PCR offers the combined benefits of highly sensitive species differentiation for medium to large sample sizes. However, no molecular diagnostic workflow currently exists for the identification of Fasciola spp. in faecal samples. A new molecular diagnostic workflow for the highly-sensitive detection and quantification of Fasciola spp. in faecal samples was developed. The technique involves sedimenting and pelleting the samples prior to DNA isolation in order to concentrate the eggs, followed by disruption by bead-beating in a benchtop homogeniser to ensure access to DNA. Although both the new molecular workflow and the traditional sedimentation technique were sensitive and specific, the new molecular workflow enabled faster sample throughput in medium to large epidemiological studies, and provided the additional benefit of speciation. Further, good correlation (R2 = 0.74–0.76) was observed between the real-time PCR values and the faecal egg count (FEC) using the new molecular workflow for all herds and sampling periods. Finally, no effect of storage in 70% ethanol was detected on sedimentation and DNA isolation outcomes; enabling transport of samples from endemic to non-endemic countries without the requirement of a complete cold chain. The commercially-available ELISA displayed poorer sensitivity, even after adjustment of the positive threshold (65–88%), compared to the sensitivity (91–100%) of the new molecular diagnostic workflow. Species-specific assays for sensitive detection of Fasciola spp. enable ante-mortem diagnosis in both human and animal settings. This includes Southeast Asia where there are potentially many undocumented human cases and where post-mortem examination of production animals can be difficult. The new molecular workflow provides a sensitive and quantitative diagnostic approach for the rapid testing of medium to large sample sizes, potentially superseding the traditional sedimentation and FEC technique and enabling surveillance programs in locations where animal and human health funding is limited. Fasciolosis caused by infection with F. hepatica, F. gigantica and their hybrid strains is an important health issue in medical and veterinary sciences. The economic impacts of infection and disease on production animals is of particular concern in low-income rural areas of developing countries, including in Southeast Asia where aquatic rice production plus low-input large ruminant husbandry, provides an ideal habitat for parasite proliferation. Here, we describe the development of a robust approach to ante-mortem diagnosis capable of differentiating between the two Fasciola spp. and their hybrid. Previously, such differentiation was based on identification of flukes collected post-mortem, because eggs of the two species have overlapping morphology. The major novelty is the demonstration that Fasciola spp. eggs, released by adults in the bile ducts, can be effectively and reproducibly broken and the content made available for DNA isolation. Coupled with part of a traditional sedimentation technique, this approach presents a new molecular diagnostic workflow capable of the specific detection of F. hepatica DNA in samples with ≤10 eggs per gram of faeces using a real-time PCR TaqMan assay. The presented workflow enables differentiation of F. hepatica and F. gigantica and their hybrid if a duplex TaqMan real-time PCR assay is included. The ability to process medium to large sample sizes in lieu of a continuous cold chain will enable further research into the epidemiology, control and public health concerns associated with Fasciola spp. infection.